Finerenone Clinical Trials

6 actively recruiting trials across 2 locations

Also known as: Angiotensin II Receptor Blockers, Firialta, Kerendia

Pipeline

Phase 3: 4Phase 4: 1

Top Sponsors

Colorado Prevention Center3
Steno Diabetes Center Copenhagen1
Second Affiliated Hospital of Soochow University1
Chinese University of Hong Kong1

Indications

Heart Disease4
Heart Failure4
Diabetes3
Acute Heart Failure1
Patients With Type 2 Diabetes1

Other3 trials

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Phase 3

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease

Phase 4

Fairhope, Alabama2 trials

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

CON-10004 Fairhope, AL Investigational Site

Phase 3

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

FIN-10004 Fairhope, AL Investigational Site

Phase 3

Glendale, Arizona1 trial

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Glendale, AZ Investigative Site 10096

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.